Biosimilar, biobetter and next generation therapeutic antibodies
Open Access
- 1 March 2011
- journal article
- Published by Informa UK Limited in mAbs
- Vol. 3 (2), 107-10
- https://doi.org/10.4161/mabs.3.2.14785
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Antibody-based therapeutics to watch in 2011mAbs, 2011
- Charge variants in IgG1mAbs, 2010
- Strategies and challenges for the next generation of therapeutic antibodiesNature Reviews Immunology, 2010
- Stability of IgG isotypes in serummAbs, 2010
- Enhanced antibody half-life improves in vivo activityNature Biotechnology, 2010
- Evolution of anti- CD20 monoclonal antibody therapeutics in oncologymAbs, 2010
- European Medicines Agency workshop on biosimilar monoclonal antibodiesmAbs, 2009
- Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding SiteScience, 2009
- Toward biosimilar monoclonal antibodiesNature Biotechnology, 2008
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-GalactoseNew England Journal of Medicine, 2008